Search
Latest
- Melatonin as a regulator of apoptosis in leukaemia: molecular mechanism and therapeutic perspectives
- From molecular basis to clinical insights: a challenging future for the vitamin D endocrine system in colorectal cancer
- Melatonin suppresses Akt/mTOR/S6K activity, induces cell apoptosis, and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing Warburg effect
- Protective effects of exogenous melatonin therapy against oxidative stress to male reproductive tissue caused by anti-cancer chemical and radiation therapy: a systematic review and meta-analysis of animal studies
- Melatonin Prevents Depression but Not Anxiety-like Behavior Produced by the Chemotherapeutic Agent Temozolomide: Implication of Doublecortin Cells and Hilar Oligodendrocytes
- Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience
- Resolution of thymoma-related pure red cell aplasia after octreotide treatment
- Of sight, and insight into melatonin’s role in breast cancer?
- Melatonin modulates tumor metabolism and mitigates metastasis
- Structural Elements Directing G Proteins and β-Arrestin Interactions with the Human Melatonin Type 2 Receptor Revealed by Natural Variants
- Structure and function of a dual antagonist of the human growth hormone and prolactin receptors with site-specific PEG conjugates
- Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats
- Efficacy, mechanism, and safety of melatonin-loaded on thermosensitive nanogels for rabbit VX2 tumor embolization: A novel design
- Melatonin modulates metabolic adaptation of pancreatic stellate cells subjected to hypoxia
- Melatonin and andrographolide synergize to inhibit the colospheroid phenotype by targeting Wnt/beta-catenin signaling
- Melatonin enhances anti-tumor immunity by targeting macrophages PD-L1 via exosomes derived from gastric cancer cells
- A meta-analysis of microRNA networks regulated by melatonin in cancer: Portrait of potential candidates for breast cancer treatment
- PDIA3 modulates genomic response to 1,25-dihydroxyvitamin D3 in squamous cell carcinoma of the skin
Most Read
- The Di Bella Method (DBM)
- All-trans-retinoic acid and cancer
- About melatonin - 1996
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- How effective is chemo therapy?
- Vademecum
- Frequently Asked Questions
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients